Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study (2019) Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, et al. Journal article Genetic risk factors for ovarian cancer and their role for endometriosis risk (2017) Burghaus S, Fasching P, Haeberle L, Rübner M, Buechner K, Blum S, Engel A, et al. Journal article Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8) (2016) Emons G, Kurzeder C, Schmalfeldt B, Neuser P, De Gregorio N, Pfisterer J, Park-Simon TW, et al. Journal article No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer (2016) Hollestelle A, Van Der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomaki K, et al. Journal article Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study (2015) Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, et al. Journal article Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an αvβ3-integrin targeted agent (2013) Harlaar NJ, Kelder W, Sarantopoulos A, Bart J, Themelis G, Van Dam GM, Ntziachristos V Journal article